FDA Approves Merck’s New Drug For A Rare Lung Disease 0 27.03.2024 00:09 Forbes.com The pharmaceutical giant’s new treatment, sotatercept, showed significant benefits for the thousands of patients suffering from pulmonary arterial hypertension in clinical trials. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
